Mupirocin: a new topical therapy for impetigo.
Mupirocin is a new, topical antibiotic effective for the treatment of impetigo. It has a unique structure, mechanism of action, and water-miscible formulation. When it is applied to an infected area three times daily, clinical improvement should be seen in 85% to 100% of patients within 3 to 5 days. It is associated with a low incidence of adverse effects and cross-resistance. Further studies are necessary to define the exact role of mupirocin in treating other primary and secondary cutaneous infections.
Putnam
C D
CD
Reynolds
M S
MS
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005227:Fatty Acids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007169:Impetigo / Q000188:drug therapy*; D016712:Mupirocin
D000900:Anti-Bacterial Agents; D005227:Fatty Acids; D016712:Mupirocin